{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:09:54Z","timestamp":1792400994531,"version":"4.4.0"},"reference-count":304,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1124\/pr.115.010629","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T03:41:20Z","timestamp":1434166880000},"page":"564-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":390,"title":["Amylin: Pharmacology, Physiology, and Clinical Potential"],"prefix":"10.1016","volume":"67","author":[{"given":"Debbie L.","family":"Hay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.115.010629_bib1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.febslet.2013.01.017","article-title":"Mechanisms of islet amyloidosis toxicity in type 2 diabetes","volume":"587","author":"Abedini","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.115.010629_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer\u2019s disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1124\/pr.115.010629_bib3","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bph.12445","article-title":"The Concise Guide to PHARMACOLOGY 2013\/14: G protein-coupled receptors","volume":"170","author":"Alexander","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.010629_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092042","article-title":"Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias","volume":"9","author":"Andreassen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1124\/pr.115.010629_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tips.2011.05.007","article-title":"Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development","volume":"32","author":"Archbold","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.115.010629_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1056-8719(00)00074-5","article-title":"Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor","volume":"42","author":"Armour","year":"1999","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/pr.115.010629_bib7","first-page":"R1654","article-title":"Chronic infusion of islet amyloid polypeptide causes anorexia in rats","volume":"271","author":"Arnelo","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib8","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1210\/jc.2006-2003","article-title":"Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study","volume":"92","author":"Aronne","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/oby.2009.478","article-title":"Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial","volume":"18","author":"Aronne","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"Supplement 1","key":"10.1124\/pr.115.010629_bib10","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.appet.2011.05.112","article-title":"Estradiol (E2) increases the acute eating-inhibitory effect of amylin in ovariectomized (OVX) rats","volume":"57","author":"Asarian","year":"2011","journal-title":"Appetite"},{"key":"10.1124\/pr.115.010629_bib11","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0196-9781(98)00127-2","article-title":"Behaviorally specific inhibition of sham feeding by amylin","volume":"19","author":"Asarian","year":"1998","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1098\/rstb.2006.1860","article-title":"Modulation of appetite by gonadal steroid hormones","volume":"361","author":"Asarian","year":"2006","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1124\/pr.115.010629_bib13","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/jc.2009-2133","article-title":"Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?","volume":"95","author":"Asmar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2011.01717.x","article-title":"Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes","volume":"166","author":"Bailey","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.010629_bib15","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1523\/JNEUROSCI.2260-13.2014","article-title":"Antipsychotic-like actions of the satiety peptide, amylin, in ventral striatal regions marked by overlapping calcitonin receptor and RAMP-1 gene expression","volume":"34","author":"Baisley","year":"2014","journal-title":"J Neurosci"},{"key":"10.1124\/pr.115.010629_bib16","doi-asserted-by":"crossref","first-page":"R1232","DOI":"10.1152\/ajpregu.2001.281.4.R1232","article-title":"Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior","volume":"281","author":"Baldo","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.physbeh.2006.07.004","article-title":"The blood-brain barrier as a regulatory interface in the gut-brain axes","volume":"89","author":"Banks","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib19","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/0024-3205(95)02197-Q","article-title":"Permeability of the blood-brain barrier to amylin","volume":"57","author":"Banks","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/pr.115.010629_bib20","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1073\/pnas.94.19.10455","article-title":"Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice","volume":"94","author":"Barrachina","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.010629_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2003.10.040","article-title":"Peripheral amylin activates circumventricular organs expressing calcitonin receptor a\/b subtypes and receptor-activity modifying proteins in the rat","volume":"997","author":"Barth","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.115.010629_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0026-895X(25)13212-4","article-title":"High affinity amylin binding sites in rat brain","volume":"44","author":"Beaumont","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.115.010629_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2007.06.016","article-title":"Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK","volume":"1162","author":"Becskei","year":"2007","journal-title":"Brain Res"},{"key":"10.1124\/pr.115.010629_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2004.10.012","article-title":"Immunohistochemical mapping of calcitonin receptors in the adult rat brain","volume":"1030","author":"Becskei","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.115.010629_bib25","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/oby.20805","article-title":"Effect of a test meal on meal responses of satiation hormones and their association to insulin resistance in obese adolescents","volume":"22","author":"Beglinger","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/pr.115.010629_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0167-0115(95)00120-4","article-title":"Activity of amylin at CGRP1-preferring receptors coupled to positive contractile response in rat ventricular cardiomyocytes","volume":"60","author":"Bell","year":"1995","journal-title":"Regul Pept"},{"key":"10.1124\/pr.115.010629_bib27","doi-asserted-by":"crossref","first-page":"R945","DOI":"10.1152\/ajpregu.00275.2010","article-title":"Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates","volume":"299","author":"Bello","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0031-9384(98)00110-3","article-title":"Synergy between amylin and cholecystokinin for inhibition of food intake in mice","volume":"64","author":"Bhavsar","year":"1998","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib29","first-page":"906","article-title":"Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes","volume":"130","author":"Bhogal","year":"1992","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib30","first-page":"1257","article-title":"Amylin\/insulin secretory ratios in morbidly obese man: inverse relationship with glucose disappearance rate","volume":"78","author":"Blackard","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib31","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1074\/jbc.M413786200","article-title":"Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking","volume":"280","author":"Bomberger","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.010629_bib32","doi-asserted-by":"crossref","first-page":"23926","DOI":"10.1074\/jbc.M501751200","article-title":"Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1","volume":"280","author":"Bomberger","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.010629_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2015.04.018","article-title":"Structural basis for receptor activity-modifying protein-dependent selective peptide recognition by a G protein-coupled receptor","author":"Booe","year":"2015","journal-title":"Mol Cell"},{"key":"10.1124\/pr.115.010629_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-0115(95)00009-Z","article-title":"In vivo central actions of rat amylin","volume":"56","author":"Bouali","year":"1995","journal-title":"Regul Pept"},{"key":"10.1124\/pr.115.010629_bib35","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1073\/pnas.84.15.5125","article-title":"Down-regulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography","volume":"84","author":"Bouizar","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.010629_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.physbeh.2011.02.015","article-title":"Amylinergic control of food intake in lean and obese rodents","volume":"105","author":"Boyle","year":"2011","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib37","first-page":"636","article-title":"Diet-induced obesity, hyperamylinemia and amylin sensitivity","volume":"54","author":"Boyle","year":"2010","journal-title":"Appetite"},{"key":"10.1124\/pr.115.010629_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.physbeh.2011.04.044","article-title":"Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin","volume":"104","author":"Boyle","year":"2011","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsbmb.2009.12.005","article-title":"Central effects of estradiol in the regulation of food intake, body weight, and adiposity","volume":"122","author":"Brown","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/pr.115.010629_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.physbeh.2009.06.010","article-title":"Estradiol and the control of food intake","volume":"99","author":"Butera","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib41","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","article-title":"Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes","volume":"53","author":"Butler","year":"2004","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.010629_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1054-3589(08)57010-4","article-title":"Preclinical behavioral models for predicting antipsychotic activity","volume":"57","author":"Castagn\u00e9","year":"2009","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pr.115.010629_bib43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0006-8993(91)91644-G","article-title":"Anorexia following the intrahypothalamic administration of amylin","volume":"539","author":"Chance","year":"1991","journal-title":"Brain Res"},{"key":"10.1124\/pr.115.010629_bib44","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/oby.2007.626","article-title":"Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects","volume":"15","author":"Chapman","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/pr.115.010629_bib45","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","article-title":"Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes","volume":"48","author":"Chapman","year":"2005","journal-title":"Diabetologia"},{"key":"10.1124\/pr.115.010629_bib46","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1074\/jbc.C200629200","article-title":"Novel receptor partners and function of receptor activity-modifying proteins","volume":"278","author":"Christopoulos","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.010629_bib47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1139\/y95-146","article-title":"Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain","volume":"73","author":"Christopoulos","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/pr.115.010629_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0026-895X(24)08983-1","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.115.010629_bib49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejphar.2012.11.010","article-title":"Effects of amylin and bupropion\/naltrexone on food intake and body weight are interactive in rodent models","volume":"698","author":"Clapper","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.115.010629_bib50","first-page":"E903","article-title":"Distribution and kinetics of amylin in humans","volume":"274","author":"Clodi","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/j.1552-4604.1996.tb04147.x","article-title":"Pharmacokinetics and pharmacodynamics of AC137 (25,28,29 tripro-amylin, human) after intravenous bolus and infusion doses in patients with insulin-dependent diabetes","volume":"36","author":"Colburn","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.115.010629_bib52","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.010629_bib53","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","article-title":"Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle","volume":"85","author":"Cooper","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.010629_bib300","first-page":"E694","article-title":"Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice","volume":"275","author":"Cornish","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib54","doi-asserted-by":"crossref","first-page":"R331","DOI":"10.1152\/ajpregu.2001.280.2.R331","article-title":"Diminished satiation in rats exposed to elevated levels of endogenous or exogenous cholecystokinin","volume":"280","author":"Covasa","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/302703a0","article-title":"Rapid development of tolerance to the behavioural actions of cholecystokinin","volume":"302","author":"Crawley","year":"1983","journal-title":"Nature"},{"key":"10.1124\/pr.115.010629_bib56","doi-asserted-by":"crossref","first-page":"18094","DOI":"10.1074\/jbc.M703544200","article-title":"Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age","volume":"282","author":"Dackor","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.010629_bib57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1083\/jcb.200312135","article-title":"Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo","volume":"164","author":"Dacquin","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1124\/pr.115.010629_bib58","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1359\/jbmr.080310","article-title":"Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice","volume":"23","author":"Davey","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1124\/pr.115.010629_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1900\/RDS.2011.8.293","article-title":"Physiology of incretins in health and disease","volume":"8","author":"Deacon","year":"2011","journal-title":"Rev Diabet Stud"},{"key":"10.1124\/pr.115.010629_bib60","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1210\/en.2002-220902","article-title":"Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary-adrenal axis","volume":"144","author":"Dhillo","year":"2003","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib61","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1471-4159.2009.06422.x","article-title":"Central amylin expression and its induction in rat dams","volume":"111","author":"Dobolyi","year":"2009","journal-title":"J Neurochem"},{"key":"10.1124\/pr.115.010629_bib62","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/13892037113149990055","article-title":"CGRP receptor antagonism and migraine therapy","volume":"14","author":"Edvinsson","year":"2013","journal-title":"Curr Protein Pept Sci"},{"key":"10.1124\/pr.115.010629_bib63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2202-12-112","article-title":"Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level","volume":"12","author":"Eftekhari","year":"2011","journal-title":"BMC Neurosci"},{"key":"10.1124\/pr.115.010629_bib64","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1113\/jphysiol.2002.018671","article-title":"Salmon calcitonin - a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents","volume":"541","author":"Eiden","year":"2002","journal-title":"J Physiol"},{"key":"10.1124\/pr.115.010629_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0168-8227(92)90074-2","article-title":"Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus","volume":"15","author":"Enoki","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1124\/pr.115.010629_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1208\/s12248-012-9409-7","article-title":"Study reanalysis using a mechanism-based pharmacokinetic\/pharmacodynamic model of pramlintide in subjects with type 1 diabetes","volume":"15","author":"Fang","year":"2013","journal-title":"AAPS J"},{"key":"10.1124\/pr.115.010629_bib67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2012.01979.x","article-title":"Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats","volume":"167","author":"Feigh","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.010629_bib68","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1463-1326.2011.01425.x","article-title":"A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats","volume":"13","author":"Feigh","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pr.115.010629_bib69","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1210\/en.2012-2172","article-title":"Amylin acts in the central nervous system to increase sympathetic nerve activity","volume":"154","author":"Fernandes-Santos","year":"2013","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib70","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1210\/jc.2011-1256","article-title":"A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial","volume":"96","author":"Fidler","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib71","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/meta.2002.32022","article-title":"The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes","volume":"51","author":"Fineman","year":"2002","journal-title":"Metabolism"},{"key":"10.1124\/pr.115.010629_bib72","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0196-9781(92)90092-H","article-title":"Differential effects of amylin on memory processing using peripheral and central routes of administration","volume":"13","author":"Flood","year":"1992","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib73","first-page":"14","article-title":"Making sense of it: roles of the sensory circumventricular organs in feeding and regulation of energy homeostasis","volume":"232","author":"Fry","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1124\/pr.115.010629_bib74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2012.11.051","article-title":"Electrophysiologically identified presynaptic mechanisms underlying amylinergic modulation of area postrema neuronal excitability in rat brain slices","volume":"1494","author":"Fukuda","year":"2013","journal-title":"Brain Res"},{"key":"10.1124\/pr.115.010629_bib75","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"10.1124\/pr.115.010629_bib76","doi-asserted-by":"crossref","first-page":"R1444","DOI":"10.1152\/ajpregu.00066.2005","article-title":"A new way of looking at eating","volume":"288","author":"Geary","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib77","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/bbrc.1998.9308","article-title":"Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin)","volume":"250","author":"Gebre-Medhin","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.010629_bib78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0169-328X(98)00269-1","article-title":"Reduced nociceptive behavior in islet amyloid polypeptide (amylin) knockout mice","volume":"63","author":"Gebre-Medhin","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/pr.115.010629_bib79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","article-title":"Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187","volume":"137","author":"Gedulin","year":"2006","journal-title":"Regul Pept"},{"key":"10.1124\/pr.115.010629_bib80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"10.1124\/pr.115.010629_bib81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2337\/diab.47.1.93","article-title":"Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats","volume":"47","author":"Gedulin","year":"1998","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.010629_bib82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/en.2013-1658","article-title":"Activity of pramlintide, rat and human amylin but not A\u03b21-42 at human amylin receptors","volume":"155","author":"Gingell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib83","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.peptides.2010.03.027","article-title":"A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor","volume":"31","author":"Gingell","year":"2010","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib84","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1210\/en.2010-0439","article-title":"Basal plasma levels of insulin, leptin, ghrelin, and amylin do not signal adiposity in rats recovering from forced overweight","volume":"151","author":"Gloy","year":"2010","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib85","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.physbeh.2004.02.002","article-title":"Chronic infusion of the amylin antagonist AC 187 increases feeding in Zucker fa\/fa rats but not in lean controls","volume":"81","author":"Grabler","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-0115(94)90204-6","article-title":"Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36","volume":"51","author":"Grandt","year":"1994","journal-title":"Regul Pept"},{"key":"10.1124\/pr.115.010629_bib87","first-page":"R1054","article-title":"Food intake and gastric emptying in rats with streptozotocin-induced diabetes","volume":"247","author":"Granneman","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib88","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s001250050654","article-title":"Accelerated gastric emptying of glucose in Zucker type 2 diabetic rats: role in postprandial hyperglycaemia","volume":"40","author":"Green","year":"1997","journal-title":"Diabetologia"},{"key":"10.1124\/pr.115.010629_bib89","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1208\/s12249-013-9987-4","article-title":"Preparation and characterization of PEGylated amylin","volume":"14","author":"Guerreiro","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1124\/pr.115.010629_bib301","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.mce.2012.11.013","article-title":"Amylin exerts osteogenic actions with different efficacy depending on the diabetic status","volume":"365","author":"Gutierrez-Rojas","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pr.115.010629_bib90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(98)00032-X","article-title":"Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake","volume":"61","author":"Halford","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.115.010629_bib91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0168-8227(92)90073-Z","article-title":"Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus","volume":"15","author":"Hanabusa","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1124\/pr.115.010629_bib92","unstructured":"Hansen TK, Schaffer L, and Lau J (2007) inventors, Novo Nordisk A\/S, assignee. Amylin derivatives. US Patent 20090099085. 2007 Mar 15."},{"key":"10.1124\/pr.115.010629_bib93","doi-asserted-by":"crossref","first-page":"11773","DOI":"10.1021\/bi901326k","article-title":"Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor","volume":"48","author":"Harikumar","year":"2009","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.010629_bib94","first-page":"F13","article-title":"Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney","volume":"272","author":"Harris","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib95","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1399-5448.2008.00490.x","article-title":"Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus","volume":"10","author":"Hassan","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1124\/pr.115.010629_bib96","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1124\/mol.104.008615","article-title":"Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes","volume":"67","author":"Hay","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.115.010629_bib97","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bph.12464","article-title":"Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activation","volume":"171","author":"Hay","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.010629_bib98","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.108.00372","article-title":"International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor","volume":"60","author":"Hay","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.115.010629_bib99","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1210\/jc.2008-2580","article-title":"Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemia","volume":"94","author":"Heptulla","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib100","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0306-4522(95)00322-A","article-title":"In vitro autoradiographic localization of the calcitonin receptor isoforms, C1a and C1b, in rat brain","volume":"69","author":"Hilton","year":"1995","journal-title":"Neuroscience"},{"key":"10.1124\/pr.115.010629_bib101","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/joe.0.1660213","article-title":"Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors","volume":"166","author":"Hilton","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1124\/pr.115.010629_bib102","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/oby.2004.76","article-title":"Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients","volume":"12","author":"Hollander","year":"2004","journal-title":"Obes Res"},{"key":"10.1124\/pr.115.010629_bib103","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1517\/14728214.9.1.155","article-title":"Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors","volume":"9","author":"Holst","year":"2004","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1124\/pr.115.010629_bib302","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.2001.16.5.958","article-title":"Amylin and bone metabolism in streptozotocin-induced diabetic rats","volume":"16","author":"Horcajada-Molteni","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1124\/pr.115.010629_bib303","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1677\/joe.0.1650663","article-title":"Amylin inhibits ovariectomy-induced bone loss in rats","volume":"165","author":"Horcajada-Molteni","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1124\/pr.115.010629_bib104","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00403371","article-title":"Disordered gastric motor function in diabetes mellitus","volume":"37","author":"Horowitz","year":"1994","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"10.1124\/pr.115.010629_bib105","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/ijo.2009.11","article-title":"Gastrointestinal hormone actions in the central regulation of energy metabolism: potential sensory roles for the circumventricular organs","volume":"33","author":"Hoyda","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1124\/pr.115.010629_bib106","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.neuroscience.2009.11.063","article-title":"Amylin suppresses acetic acid-induced visceral pain and spinal c-fos expression in the mouse","volume":"165","author":"Huang","year":"2010","journal-title":"Neuroscience"},{"key":"10.1124\/pr.115.010629_bib107","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4158\/EP09044.ORR1","article-title":"Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study","volume":"15","author":"Huffman","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1124\/pr.115.010629_bib108","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/dc07-2433","article-title":"Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide: interventional studies in humans","volume":"31","author":"Hwang","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1124\/pr.115.010629_bib109","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000084488","article-title":"Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis","volume":"5","author":"Isaksson","year":"2005","journal-title":"Pancreatology"},{"key":"10.1124\/pr.115.010629_bib110","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s11695-012-0621-4","article-title":"Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects","volume":"22","author":"Jacobsen","year":"2012","journal-title":"Obes Surg"},{"key":"10.1124\/pr.115.010629_bib111","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/bbrc.2000.3093","article-title":"Transgenic mice reveal novel sites of calcitonin receptor gene expression during development","volume":"274","author":"Jagger","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 2","key":"10.1124\/pr.115.010629_bib112","first-page":"235A","article-title":"The selection of pramlintide for clinical evaluation (Abstract)","volume":"45","author":"Janes","year":"1996","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.010629_bib113","first-page":"1643","article-title":"Gastric emptying in early noninsulin-dependent diabetes mellitus","volume":"37","author":"Jones","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1124\/pr.115.010629_bib114","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4614-2364-5_5","article-title":"Understanding RAMPs through genetically engineered mouse models","volume":"744","author":"Kadmiel","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pr.115.010629_bib115","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1210\/me.2010-0400","article-title":"Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice","volume":"25","author":"Kadmiel","year":"2011","journal-title":"Mol Endocrinol"},{"key":"10.1124\/pr.115.010629_bib116","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-5793(89)81527-3","article-title":"Secretion of islet amyloid polypeptide in response to glucose","volume":"259","author":"Kanatsuka","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.115.010629_bib117","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0091270010372625","article-title":"Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials","volume":"51","author":"Karsdal","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.115.010629_bib118","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s001250050092","article-title":"Role of islet amyloid polypeptide secretion in insulin-resistant humans","volume":"37","author":"Kautzky-Willer","year":"1994","journal-title":"Diabetologia"},{"key":"10.1124\/pr.115.010629_bib119","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1556\/APhysiol.97.2010.4.2","article-title":"Positive inotropic, positive chronotropic and coronary vasodilatory effects of rat amylin: mechanisms of amylin-induced positive inotropy","volume":"97","author":"Kaygisiz","year":"2010","journal-title":"Acta Physiol Hung"},{"key":"10.1124\/pr.115.010629_bib120","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/ncomms6215","article-title":"Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts","volume":"5","author":"Keller","year":"2014","journal-title":"Nat Commun"},{"key":"10.1124\/pr.115.010629_bib121","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.1999.tb09262.x","article-title":"Functional specificity of ventral striatal compartments in appetitive behaviors","volume":"877","author":"Kelley","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/pr.115.010629_bib122","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1517\/17460441.2013.792804","article-title":"New advances in models and strategies for developing anti-obesity drugs","volume":"8","author":"Kim","year":"2013","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/pr.115.010629_bib123","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4158\/EP.15.3.229","article-title":"Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used","volume":"15","author":"King","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1124\/pr.115.010629_bib124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/dia.2009.0096","article-title":"Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients","volume":"12","author":"King","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"Suppl 1","key":"10.1124\/pr.115.010629_bib125","first-page":"76","article-title":"Amygdala activation by leptin predicts food intake in lean men","volume":"18","author":"Klopfenstein","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/pr.115.010629_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011376","article-title":"Hyperleptinemia is required for the development of leptin resistance","volume":"5","author":"Knight","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1124\/pr.115.010629_bib127","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s001250050646","article-title":"Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM","volume":"40","author":"Kong","year":"1997","journal-title":"Diabetologia"},{"key":"10.1124\/pr.115.010629_bib128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001250050949","article-title":"The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM","volume":"41","author":"Kong","year":"1998","journal-title":"Diabetologia"},{"key":"10.1124\/pr.115.010629_bib129","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1039\/C4OB01208A","article-title":"Convergent chemoenzymatic synthesis of a library of glycosylated analogues of pramlintide: structure-activity relationships for amylin receptor agonism","volume":"12","author":"Kowalczyk","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1124\/pr.115.010629_bib130","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2337\/db14-0645","article-title":"Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling","volume":"64","author":"Le Foll","year":"2015","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.010629_bib131","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2147\/DDDT.S58459","article-title":"Liraglutide and obesity: a review of the data so far","volume":"9","author":"Ladenheim","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1124\/pr.115.010629_bib132","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/bbrc.1997.7465","article-title":"Renal elimination of islet amyloid polypeptide","volume":"239","author":"Leckstr\u00f6m","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.010629_bib133","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3349\/ymj.2011.52.2.257","article-title":"Delayed response of amylin levels after an oral glucose challenge in children with Prader-Willi syndrome","volume":"52","author":"Lee","year":"2011","journal-title":"Yonsei Med J"},{"key":"10.1124\/pr.115.010629_bib134","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.regpep.2012.08.006","article-title":"[D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK\/6-m db\/db mice","volume":"179","author":"Leinung","year":"2012","journal-title":"Regul Pept"},{"key":"10.1124\/pr.115.010629_bib135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/JME-13-0021","article-title":"G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection","volume":"51","author":"Lenhart","year":"2013","journal-title":"J Mol Endocrinol"},{"key":"10.1124\/pr.115.010629_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.26.1.1","article-title":"Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps","volume":"26","author":"Levetan","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1124\/pr.115.010629_bib137","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1152\/ajpregu.2000.278.1.R231","article-title":"Defense of body weight against chronic caloric restriction in obesity-prone and -resistant rats","volume":"278","author":"Levin","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib138","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diab.40.12.1615","article-title":"Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes","volume":"40","author":"Ludvik","year":"1991","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.010629_bib139","first-page":"13","article-title":"No measurable effect of amylin on lipolysis in either white or brown isolated adipocytes from rats","volume":"6","author":"Lupien","year":"1993","journal-title":"Diabetes Nutr Metab"},{"key":"10.1124\/pr.115.010629_bib140","first-page":"3","article-title":"Transmembrane signaling by G protein-coupled receptors","volume":"332","author":"Luttrell","year":"2006","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.115.010629_bib141","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.physbeh.2006.04.001","article-title":"Amylinergic control of food intake","volume":"89","author":"Lutz","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib142","doi-asserted-by":"crossref","first-page":"R1475","DOI":"10.1152\/ajpregu.00703.2009","article-title":"The role of amylin in the control of energy homeostasis","volume":"298","author":"Lutz","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib143","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","article-title":"Control of energy homeostasis by amylin","volume":"69","author":"Lutz","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pr.115.010629_bib144","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-3-642-24716-3_10","article-title":"Effects of amylin on eating and adiposity","volume":"209","author":"Lutz","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.010629_bib145","first-page":"R1777","article-title":"Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers","volume":"274","author":"Lutz","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib146","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0031-9384(94)90076-0","article-title":"Reduction of food intake in rats by intraperitoneal injection of low doses of amylin","volume":"55","author":"Lutz","year":"1994","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib147","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0196-9781(94)00203-I","article-title":"Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin","volume":"16","author":"Lutz","year":"1995","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib148","series-title":"Appetite and Food Intake: Behavioral and Physiological Consideration","first-page":"163","article-title":"Gastrointestinal factors in appetite and food research - animal research","author":"Lutz","year":"2008"},{"key":"10.1124\/pr.115.010629_bib149","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0031-9384(95)02067-5","article-title":"Amylin decreases meal size in rats","volume":"58","author":"Lutz","year":"1995","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib150","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.ijo.0801664","article-title":"The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema\/nucleus of the solitary tract (AP\/NTS) lesioned rats","volume":"25","author":"Lutz","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1124\/pr.115.010629_bib151","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(97)00503-X","article-title":"Evidence for a physiological role of central calcitonin gene-related peptide (CGRP) receptors in the control of food intake in rats","volume":"230","author":"Lutz","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.115.010629_bib152","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0196-9781(98)00114-4","article-title":"Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats","volume":"19","author":"Lutz","year":"1998","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib153","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0196-9781(97)00292-1","article-title":"Lesion of the area postrema\/nucleus of the solitary tract (AP\/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats","volume":"19","author":"Lutz","year":"1998","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib154","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0031-9384(00)00302-4","article-title":"Attenuation of the anorectic effects of cholecystokinin and bombesin by the specific amylin antagonist AC 253","volume":"70","author":"Lutz","year":"2000","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib155","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.beem.2009.03.009","article-title":"Insulin secretion in healthy subjects and patients with Type 2 diabetes\u2014role of the gastrointestinal tract","volume":"23","author":"Ma","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib156","doi-asserted-by":"crossref","first-page":"R1855","DOI":"10.1152\/ajpregu.00297.2007","article-title":"Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight","volume":"293","author":"Mack","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib157","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1463-1326.2011.01465.x","article-title":"Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide","volume":"13","author":"Mack","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pr.115.010629_bib158","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ijo.2009.238","article-title":"Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight","volume":"34","author":"Mack","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1124\/pr.115.010629_bib159","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/dmrr.263","article-title":"Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity","volume":"18","author":"Mather","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1124\/pr.115.010629_bib160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdiacomp.2006.10.005","article-title":"The metabolic syndrome in type 1 diabetes: does it exist and does it matter?","volume":"22","author":"McGill","year":"2008","journal-title":"J Diabetes Complications"},{"key":"10.1124\/pr.115.010629_bib161","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1124\/pr.115.010629_bib162","unstructured":"Mehta NM, Sturmer A, and Stern W, and Gilligan JP (2013) inventors, Unigene Laboratories, assignee. Treatment for obesity. US Patent 8378067. 2013 Feb 19."},{"key":"10.1124\/pr.115.010629_bib163","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00087.2015","article-title":"Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake","author":"Mietlicki-Baase","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib164","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/npp.2013.66","article-title":"Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake","volume":"38","author":"Mietlicki-Baase","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.115.010629_bib165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.physbeh.2013.02.012","article-title":"Circumventricular organs: targets for integration of circulating fluid and energy balance signals?","volume":"121","author":"Mimee","year":"2013","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib166","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.physbeh.2004.01.006","article-title":"Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats","volume":"81","author":"Mollet","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib167","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0196-9781(02)00280-2","article-title":"Endogenous amylin contributes to the anorectic effects of cholecystokinin and bombesin","volume":"24","author":"Mollet","year":"2003","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib168","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0196-9781(02)00288-7","article-title":"Histamine H1 receptors in the ventromedial hypothalamus mediate the anorectic action of the pancreatic hormone amylin","volume":"24","author":"Mollet","year":"2003","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib169","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc10-0518","article-title":"Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans","volume":"34","author":"Moon","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1124\/pr.115.010629_bib170","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1210\/en.2007-1735","article-title":"Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors","volume":"149","author":"Morfis","year":"2008","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib171","first-page":"R178","article-title":"Modulation of food intake by peripherally administered amylin","volume":"267","author":"Morley","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib172","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0091-3057(93)90169-T","article-title":"Anorectic effects of amylin in rats over the life span","volume":"44","author":"Morley","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.115.010629_bib173","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0091-3057(96)00168-2","article-title":"Amylin and food intake in mice: effects on motivation to eat and mechanism of action","volume":"56","author":"Morley","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.115.010629_bib174","first-page":"S25","article-title":"Pharmacokinetic and hyperglycaemic effects of the amylin analogue, AC137, in man","volume":"10","author":"Moyses","year":"1993","journal-title":"Diabetic Med"},{"key":"10.1124\/pr.115.010629_bib175","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1210\/endo.140.6.6930","article-title":"An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3","volume":"140","author":"Muff","year":"1999","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib176","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/psc.2408","article-title":"Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21","volume":"18","author":"M\u00fcller","year":"2012","journal-title":"J Pept Sci"},{"key":"10.1124\/pr.115.010629_bib177","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-328X(99)00335-6","article-title":"Localization of calcitonin receptor mRNA in the mouse brain: coexistence with serotonin transporter mRNA","volume":"76","author":"Nakamoto","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/pr.115.010629_bib178","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1620\/tjem.139.205","article-title":"Disturbances of the alimentary tract motility and hypermotilinemia in the patients with diabetes mellitus","volume":"139","author":"Nakanome","year":"1983","journal-title":"Tohoku J Exp Med"},{"key":"10.1124\/pr.115.010629_bib179","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0006-291X(90)90389-5","article-title":"Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulation","volume":"169","author":"Nakazato","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.010629_bib180","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jcem.87.3.8355","article-title":"Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers","volume":"87","author":"Nauck","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1124\/pr.115.010629_bib181","first-page":"A433","article-title":"AC2307, an amylin mimetic, reduced 24-h food intake in obese subjects (Abstract)","volume":"57","author":"Nicandro","year":"2008","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.010629_bib182","first-page":"1083","article-title":"Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus","volume":"81","author":"Nyholm","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib183","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0026-0495(99)90232-9","article-title":"The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus","volume":"48","author":"Nyholm","year":"1999","journal-title":"Metabolism"},{"key":"10.1124\/pr.115.010629_bib184","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI114528","article-title":"Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment","volume":"85","author":"Ogawa","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.115.010629_bib185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(83)90334-7","article-title":"Localization of calcitonin binding sites in rat central nervous system: evidence of its neuroactivity","volume":"265","author":"Olgiati","year":"1983","journal-title":"Brain Res"},{"key":"10.1124\/pr.115.010629_bib186","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.0953-816x.2001.01688.x","article-title":"Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat","volume":"14","author":"Oliver","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.115.010629_bib187","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/00365521.2011.638392","article-title":"Food intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP","volume":"47","author":"Olsson","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1124\/pr.115.010629_bib188","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.peptides.2008.02.002","article-title":"Central and peripheral administration of amylin induces energy expenditure in anesthetized rats","volume":"29","author":"Osaka","year":"2008","journal-title":"Peptides"},{"key":"10.1124\/pr.115.010629_bib189","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.physbeh.2007.03.017","article-title":"Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin","volume":"91","author":"Osto","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib190","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1210\/endo.138.8.5312","article-title":"Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line","volume":"138","author":"Perry","year":"1997","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib191","first-page":"E156","article-title":"Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity","volume":"267","author":"Pieber","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib192","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0024-3205(93)90514-4","article-title":"CGRP 8-37[correction of 8-27] blocks the inhibition of gastric emptying induced by intravenous injection of alpha-CGRP in rats","volume":"52","author":"Plourde","year":"1993","journal-title":"Life Sci"},{"key":"10.1124\/pr.115.010629_bib193","doi-asserted-by":"crossref","first-page":"R340","DOI":"10.1152\/ajpregu.00380.2011","article-title":"Involvement of the extracellular signal-regulated kinase 1\/2 signaling pathway in amylin\u2019s eating inhibitory effect","volume":"302","author":"Potes","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib194","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.physbeh.2010.03.001","article-title":"Brainstem mechanisms of amylin-induced anorexia","volume":"100","author":"Potes","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2010.03.114","article-title":"Identification of central projections from amylin-activated neurons to the lateral hypothalamus","volume":"1334","author":"Potes","year":"2010","journal-title":"Brain Res"},{"key":"10.1124\/pr.115.010629_bib196","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.appet.2010.04.164","article-title":"Amylin induces ERK 1\/2 phosphorylation in structures of the AP\/NTS-LPB-Ce-BSTL axis","volume":"54","author":"Potes","year":"2010","journal-title":"Appetite"},{"key":"10.1124\/pr.115.010629_bib197","doi-asserted-by":"crossref","first-page":"R623","DOI":"10.1152\/ajpregu.00791.2009","article-title":"Noradrenergic neurons of the area postrema mediate amylin\u2019s hypophagic action","volume":"299","author":"Potes","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib198","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","article-title":"International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors","volume":"54","author":"Poyner","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.115.010629_bib199","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1152\/ajpendo.00242.2009","article-title":"Fatty acids induce amylin expression and secretion by pancreatic \u03b2-cells","volume":"298","author":"Qi","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib200","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/mol.108.047142","article-title":"Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function","volume":"74","author":"Qi","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.115.010629_bib201","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2012.02197.x","article-title":"Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant \u0394(1-47)hCT((a)) function","volume":"168","author":"Qi","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.010629_bib202","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/pr.115.010629_bib203","doi-asserted-by":"crossref","first-page":"E1576","DOI":"10.1152\/ajpendo.00058.2012","article-title":"Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese rats","volume":"302","author":"Reidelberger","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib204","doi-asserted-by":"crossref","first-page":"R605","DOI":"10.1152\/ajpregu.2001.280.3.R605","article-title":"Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats","volume":"280","author":"Reidelberger","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib205","doi-asserted-by":"crossref","first-page":"R1395","DOI":"10.1152\/ajpregu.00597.2001","article-title":"Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats","volume":"282","author":"Reidelberger","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib206","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2337\/dc09-0395","article-title":"Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes","volume":"32","author":"Riddle","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1124\/pr.115.010629_bib207","doi-asserted-by":"crossref","first-page":"R1833","DOI":"10.1152\/ajpregu.2001.281.6.R1833","article-title":"Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP","volume":"281","author":"Riediger","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib208","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(02)00482-2","article-title":"Amylin and glucose co-activate area postrema neurons of the rat","volume":"328","author":"Riediger","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.115.010629_bib209","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01697-2","article-title":"Pharmacological characterisation of amylin-related peptides activating subfornical organ neurones","volume":"837","author":"Riediger","year":"1999","journal-title":"Brain Res"},{"key":"10.1124\/pr.115.010629_bib210","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1152\/ajpregu.00333.2003","article-title":"The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis","volume":"286","author":"Riediger","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib211","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0031-9384(95)00108-U","article-title":"Central insulin enhances sensitivity to cholecystokinin","volume":"58","author":"Riedy","year":"1995","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib212","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1515\/jpem.2010.204","article-title":"Changes in dynamic insulin and gastrointestinal hormone secretion in obese children","volume":"23","author":"Roth","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib213","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1210\/en.2007-0898","article-title":"Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity","volume":"148","author":"Roth","year":"2007","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib214","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1463-1326.2012.01570.x","article-title":"Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents","volume":"14","author":"Roth","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pr.115.010629_bib215","doi-asserted-by":"crossref","first-page":"E1112","DOI":"10.1152\/ajpendo.00395.2007","article-title":"Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats","volume":"293","author":"Roth","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib304","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1210\/en.2006-0393","article-title":"Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression","volume":"147","author":"Roth","year":"2006","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib216","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archneurol.2008.581","article-title":"Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications","volume":"66","author":"Roth","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1124\/pr.115.010629_bib217","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.010629_bib218","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/187152208787169189","article-title":"Amylin-based pharmacotherapy \u2013 past, present & future","volume":"8","author":"Roth","year":"2008","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"key":"10.1124\/pr.115.010629_bib219","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/ijo.2008.91","article-title":"Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats","volume":"32","author":"Roth","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1124\/pr.115.010629_bib220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0167-0115(97)01034-3","article-title":"Comparison of Fos induced in rat brain by GLP-1 and amylin","volume":"71","author":"Rowland","year":"1997","journal-title":"Regul Pept"},{"key":"10.1124\/pr.115.010629_bib221","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1210\/endo.142.11.8593","article-title":"Inhibition of central amylin signaling increases food intake and body adiposity in rats","volume":"142","author":"Rushing","year":"2001","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib222","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/endo.141.2.7378","article-title":"Amylin: a novel action in the brain to reduce body weight","volume":"141","author":"Rushing","year":"2000","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib223","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/HYPERTENSIONAHA.109.148171","article-title":"Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension","volume":"55","author":"Sabharwal","year":"2010","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.010629_bib224","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(99)00721-9","article-title":"Positive inotropy of calcitonin gene-related peptide and amylin on porcine isolated myocardium","volume":"385","author":"Saetrum Opgaard","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.115.010629_bib225","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.2000.278.6.G946","article-title":"Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition","volume":"278","author":"Samsom","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/pr.115.010629_bib226","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1177\/193229681200600633","article-title":"Simultaneous use of two external subcutaneous pumps delivering insulin and SYMLIN: use of a double-pump system","volume":"6","author":"Schorr","year":"2012","journal-title":"J Diabetes Sci Tech"},{"key":"10.1124\/pr.115.010629_bib227","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2174\/092986730611220401164504","article-title":"Calcitonin","volume":"6","author":"Sexton","year":"1999","journal-title":"Curr Med Chem"},{"key":"10.1124\/pr.115.010629_bib228","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0197-0186(88)90171-4","article-title":"Evidence for a new subclass of calcitonin\/ calcitonin gene-related peptide binding site in rat brain","volume":"12","author":"Sexton","year":"1988","journal-title":"Neurochem Int"},{"key":"10.1124\/pr.115.010629_bib229","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cne.903410403","article-title":"In vitro autoradiographic localization of calcitonin binding sites in human medulla oblongata","volume":"341","author":"Sexton","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.115.010629_bib230","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"10.1124\/pr.115.010629_bib231","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-8993(99)02286-6","article-title":"Amylin compared with calcitonin: competitive binding studies in rat brain and antinociceptive activity","volume":"854","author":"Sibilia","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/pr.115.010629_bib232","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1152\/ajpendo.2001.280.3.E443","article-title":"Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas","volume":"280","author":"Silvestre","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib233","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1463-1326.2010.01337.x","article-title":"The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis","volume":"13","author":"Singh-Franco","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pr.115.010629_bib234","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1139\/y95-131","article-title":"Comparative immunohistochemical distribution of amylin-like and calcitonin gene related peptide like immunoreactivity in the rat central nervous system","volume":"73","author":"Skofitsch","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/pr.115.010629_bib235","doi-asserted-by":"crossref","first-page":"R676","DOI":"10.1152\/ajpregu.00090.2012","article-title":"Amylin blunts hyperphagia and reduces weight and fat gain during recovery in socially stressed rats","volume":"303","author":"Smeltzer","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.010629_bib236","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/dc08-0029","article-title":"Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity","volume":"31","author":"Smith","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1124\/pr.115.010629_bib237","doi-asserted-by":"crossref","first-page":"E620","DOI":"10.1152\/ajpendo.00217.2007","article-title":"Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study","volume":"293","author":"Smith","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib238","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1046\/j.1365-2826.2003.01064.x","article-title":"Receptor activity modifying protein 2 distribution in the rat central nervous system and regulation by changes in blood pressure","volume":"15","author":"Stachniak","year":"2003","journal-title":"J Neuroendocrinol"},{"key":"10.1124\/pr.115.010629_bib239","first-page":"R978","article-title":"Hepatic portal insulin antibody infusion increases, but insulin does not alter, spontaneous meal size in rats","volume":"269","author":"Surina-Baumgartner","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib240","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1096\/fj.11-191841","article-title":"Amylin is a novel neuropeptide with potential maternal functions in the rat","volume":"26","author":"Szab\u00f3","year":"2012","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.010629_bib241","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.RES.0000200737.63865.58","article-title":"Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2","volume":"98","author":"Tam","year":"2006","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.010629_bib242","first-page":"285","article-title":"Calcitonin binding sites in bone: relationships to biological response and \u201cescape.\u201d","volume":"34","author":"Tashjian","year":"1978","journal-title":"Recent Prog Horm Res"},{"key":"10.1124\/pr.115.010629_bib243","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(24)39040-8","article-title":"Amylin receptor phenotypes derived from human calcitonin receptor\/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment","volume":"294","author":"Tilakaratne","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.115.010629_bib244","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/002215549904700801","article-title":"Gastric amylin expression. Cellular identity and lack of requirement for the homeobox protein PDX-1. A study in normal and PDX-1-deficient animals with a cautionary note on antiserum evaluation","volume":"47","author":"Tingstedt","year":"1999","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pr.115.010629_bib245","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1002\/chem.201303303","article-title":"Glycosylation of pramlintide: synthetic glycopeptides that display in vitro and in vivo activities as amylin receptor agonists","volume":"19","author":"Tomabechi","year":"2013","journal-title":"Chemistry"},{"key":"10.1124\/pr.115.010629_bib246","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1210\/en.2008-0770","article-title":"Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms","volume":"149","author":"Trevaskis","year":"2008","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib247","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/oby.2009.187","article-title":"Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats","volume":"18","author":"Trevaskis","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/pr.115.010629_bib248","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tem.2010.03.006","article-title":"Insights into amylin-leptin synergy","volume":"21","author":"Trevaskis","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/pr.115.010629_bib249","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1210\/en.2010-0590","article-title":"Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats","volume":"151","author":"Trevaskis","year":"2010","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/en.2009-0546","article-title":"Mechanisms of amylin\/leptin synergy in rodent models","volume":"151","author":"Turek","year":"2010","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib251","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bone.2010.09.013","article-title":"The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption","volume":"48","author":"Turner","year":"2011","journal-title":"Bone"},{"key":"10.1124\/pr.115.010629_bib252","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1124\/mol.106.024257","article-title":"A critical role for the short intracellular C terminus in receptor activity-modifying protein function","volume":"70","author":"Udawela","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.115.010629_bib253","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1124\/mol.105.021915","article-title":"Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors","volume":"69","author":"Udawela","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.115.010629_bib254","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.regpep.2007.08.003","article-title":"The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors","volume":"145","author":"Udawela","year":"2008","journal-title":"Regul Pept"},{"key":"10.1124\/pr.115.010629_bib255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0169-328X(01)00179-6","article-title":"Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain","volume":"93","author":"Ueda","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/pr.115.010629_bib256","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2007-978923","article-title":"Nephrectomy decreases amylin and pramlintide clearance in rats","volume":"30","author":"Vine","year":"1998","journal-title":"Horm Metab Res"},{"key":"10.1124\/pr.115.010629_bib257","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-2007-978924","article-title":"Effects of rat amylin on renal function in the rat","volume":"30","author":"Vine","year":"1998","journal-title":"Horm Metab Res"},{"key":"10.1124\/pr.115.010629_bib258","doi-asserted-by":"crossref","DOI":"10.1096\/fj.15-270553","article-title":"Islet amyloid polypeptide exerts a novel autocrine action in \u03b2-cell signaling and proliferation","author":"Visa","year":"2015","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.010629_bib259","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.197","article-title":"A second trigeminal CGRP receptor: function and expression of the AMY1 receptor","author":"Walker","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1124\/pr.115.010629_bib260","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1210\/en.2010-0284","article-title":"Mice lacking the neuropeptide \u03b1-calcitonin gene-related peptide are protected against diet-induced obesity","volume":"151","author":"Walker","year":"2010","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.010629_bib261","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2741\/3885","article-title":"Leptin receptor signaling: pathways to leptin resistance","volume":"16","author":"Wauman","year":"2011","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1124\/pr.115.010629_bib262","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/dc12-0330","article-title":"Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes","volume":"35","author":"Weinzimer","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1124\/pr.115.010629_bib263","first-page":"R776","article-title":"Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats","volume":"246","author":"West","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.010629_bib264","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.115.010629_bib265","first-page":"414","article-title":"Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone","volume":"127","author":"Westermark","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.115.010629_bib266","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.010629_bib267","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.010629_bib268","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajhp\/62.8.816","article-title":"Properties of pramlintide and insulin upon mixing","volume":"62","author":"Weyer","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1124\/pr.115.010629_bib269","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/1381612013397357","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control","volume":"7","author":"Weyer","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.115.010629_bib270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.regpep.2008.03.010","article-title":"Gastric emptying in response to IAPP and CCK in rats with subdiaphragmatic afferent vagotomy","volume":"148","author":"Wickbom","year":"2008","journal-title":"Regul Pept"},{"key":"10.1124\/pr.115.010629_bib271","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.physbeh.2007.02.012","article-title":"The acute effect of amylin and salmon calcitonin on energy expenditure","volume":"91","author":"Wielinga","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib272","first-page":"409","article-title":"Effect of peripheral and central amylin on energy expenditure and body temperature","volume":"91","author":"Wielinga","year":"2008","journal-title":"Appetite"},{"key":"10.1124\/pr.115.010629_bib273","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.physbeh.2010.04.012","article-title":"Central amylin acts as an adiposity signal to control body weight and energy expenditure","volume":"101","author":"Wielinga","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib274","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.2337\/db06-1755","article-title":"Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance","volume":"57","author":"Wong","year":"2008","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.010629_bib275","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.physbeh.2005.08.060","article-title":"Signals that influence food intake and body weight","volume":"86","author":"Woods","year":"2005","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib276","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/01.HYP.30.3.455","article-title":"Increased density of renal amylin binding sites in experimental hypertension","volume":"30","author":"Wookey","year":"1997","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.010629_bib277","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1440-1681.1998.tb02272.x","article-title":"Amylin: physiological roles in the kidney and a hypothesis for its role in hypertension","volume":"25","author":"Wookey","year":"1998","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/pr.115.010629_bib278","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1523-1755.1998.00722.x","article-title":"Amylin as a growth factor during fetal and postnatal development of the rat kidney","volume":"53","author":"Wookey","year":"1998","journal-title":"Kidney Int"},{"key":"10.1124\/pr.115.010629_bib279","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2013.07.009","article-title":"Molecular links between Alzheimer\u2019s disease and diabetes mellitus","volume":"250","author":"Yang","year":"2013","journal-title":"Neuroscience"},{"issue":"Suppl 2","key":"10.1124\/pr.115.010629_bib280","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/(SICI)1096-9136(199706)14:2+<S14::AID-DIA398>3.0.CO;2-Q","article-title":"Role of amylin in nutrient intake - animal studies","volume":"14","author":"Young","year":"1997","journal-title":"Diabet Med"},{"key":"10.1124\/pr.115.010629_bib281","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1054-3589(05)52014-3","article-title":"Cardiovascular effects","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pr.115.010629_bib282","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1054-3589(05)52006-4","article-title":"Inhibition of gastric emptying","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pr.115.010629_bib283","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1054-3589(05)52008-8","article-title":"Inhibition of glucagon secretion","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pr.115.010629_bib284","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1054-3589(05)52002-7","article-title":"Tissue expression and secretion of amylin","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pr.115.010629_bib285","first-page":"524","article-title":"Roles of amylin in diabetes and in regulation of nutrient load","volume":"14","author":"Young","year":"1998","journal-title":"Nutrition"},{"key":"10.1124\/pr.115.010629_bib286","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s001250051265","article-title":"Amylin innocent in essential hypertension?","volume":"42","author":"Young","year":"1999","journal-title":"Diabetologia"},{"key":"10.1124\/pr.115.010629_bib287","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2012.03.019","article-title":"Brainstem sensing of meal-related signals in energy homeostasis","volume":"63","author":"Young","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.115.010629_bib288","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00401833","article-title":"Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin","volume":"38","author":"Young","year":"1995","journal-title":"Diabetologia"},{"key":"10.1124\/pr.115.010629_bib289","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-0495(96)90192-4","article-title":"Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake","volume":"45","author":"Young","year":"1996","journal-title":"Metabolism"},{"key":"10.1124\/pr.115.010629_bib290","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin","volume":"37","author":"Young","year":"1996","journal-title":"Drug Dev Res"},{"key":"10.1124\/pr.115.010629_bib291","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-5793(91)81113-M","article-title":"Amylin injection causes elevated plasma lactate and glucose in the rat","volume":"291","author":"Young","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.115.010629_bib292","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1517\/14656566.2011.581663","article-title":"Pramlintide and the treatment of diabetes: a review of the data since its introduction","volume":"12","author":"Younk","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/pr.115.010629_bib293","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/gast.2002.34176","article-title":"Amylin, released from the gastric fundus, stimulates somatostatin and thus inhibits histamine and acid secretion in mice","volume":"123","author":"Zaki","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.115.010629_bib294","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.physbeh.2006.05.038","article-title":"The role of leptin in leptin resistance and obesity","volume":"88","author":"Zhang","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.115.010629_bib295","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db10-0692","article-title":"Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice","volume":"60","author":"Zhang","year":"2011","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.010629_bib296","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1523\/JNEUROSCI.4542-06.2007","article-title":"Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion","volume":"27","author":"Zhang","year":"2007","journal-title":"J Neurosci"},{"key":"10.1124\/pr.115.010629_bib297","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11684-013-0263-5","article-title":"Leptin signaling and leptin resistance","volume":"7","author":"Zhou","year":"2013","journal-title":"Fr Medecine"},{"key":"10.1124\/pr.115.010629_bib298","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.115.010629_bib299","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.physbeh.2013.02.006","article-title":"Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli","volume":"112\u2013113","author":"Z\u00fcger","year":"2013","journal-title":"Physiol Behav"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724011505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724011505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.115.010629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T10:40:05Z","timestamp":1739875205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724011505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":304,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0031699724011505"],"URL":"https:\/\/doi.org\/10.1124\/pr.115.010629","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amylin: Pharmacology, Physiology, and Clinical Potential","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.115.010629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}